z-logo
open-access-imgOpen Access
β-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology
Author(s) -
Elizabeth A. Proctor,
David D. Mowrey,
Nikolay V. Dokholyan
Publication year - 2019
Publication title -
plos computational biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.628
H-Index - 182
eISSN - 1553-7358
pISSN - 1553-734X
DOI - 10.1371/journal.pcbi.1007225
Subject(s) - sod1 , amyotrophic lateral sclerosis , neurodegeneration , superoxide dismutase , serine , alanine , chemistry , biochemistry , protein aggregation , biology , microbiology and biotechnology , amino acid , medicine , enzyme , disease , pathology
Exposure to the environmental toxin β-methylamino-L-alanine (BMAA) is linked to amyotrophic lateral sclerosis (ALS), but its disease-promoting mechanism remains unknown. We propose that incorporation of BMAA into the ALS-linked protein Cu,Zn superoxide dismutase (SOD1) upon translation promotes protein misfolding and aggregation, which has been linked to ALS onset and progression. Using molecular simulation and predictive energetic computation, we demonstrate that substituting any serine with BMAA in SOD1 results in structural destabilization and aberrant dynamics, promoting neurotoxic SOD1 aggregation. We propose that translational incorporation of BMAA into SOD1 is directly responsible for its toxicity in neurodegeneration, and BMAA modification of SOD1 may serve as a biomarker of ALS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom